Department of Cardiology, Shanghai Songjiang District Central Hospital, Shanghai, China.
Department of Intensive Care Unit, Kailuan General Hospital, North China University of Science and Technology, Tangshan, China.
Hypertens Res. 2024 Apr;47(4):921-933. doi: 10.1038/s41440-023-01529-y. Epub 2023 Dec 15.
The increase in heart failure risk in the diabetic population when hypertension and atherosclerosis are both present is still inconclusive. The aim of this study was to explore the effects of hypertension combined with atherosclerosis in diabetic population on the risk of heart failure. We selected 10,711 patients with diabetes who participated in the Kailuan study and completed brachial-ankle pulse wave velocity (baPWV) testing for statistical analysis. The subjects were divided into the non-hypertensive non-atherosclerotic, hypertensive, atherosclerotic, and hypertensive atherosclerotic groups based on their history of hypertension and atherosclerosis. At a median follow-up of 4.15 years, 227 cases of heart failure occurred. Compared with the non-hypertensive non-atherosclerotic group, the multifactorial Cox proportional risk regression model showed that the hazard ratio (HR) for heart failure in the hypertensive atherosclerotic group was 3.08 (95% confidence interval [CI]: 1.32-7.16), whereas the HR decreased to 2.38 (95% CI: 1.01-5.63) after gradual correction of lipid-lowering, glucose-lowering, and antihypertensive drugs. The subgroup analysis and sensitivity analysis were consistent with that of total population. In conclusion, patients with diabetes exposed to both hypertension and atherosclerosis had an increased heart failure risk, which was attenuated by the use of lipid-lowering, glucose-lowering, and antihypertensive drugs.
当高血压和动脉粥样硬化同时存在于糖尿病患者中时,心力衰竭风险的增加仍然不确定。本研究旨在探讨糖尿病患者中高血压合并动脉粥样硬化对心力衰竭风险的影响。我们选择了 10711 名参加开滦研究并完成了臂踝脉搏波速度(baPWV)检测的糖尿病患者进行统计分析。根据高血压和动脉粥样硬化病史,将受试者分为非高血压非动脉粥样硬化、高血压、动脉粥样硬化和高血压动脉粥样硬化组。在中位数为 4.15 年的随访中,发生了 227 例心力衰竭。与非高血压非动脉粥样硬化组相比,多因素 Cox 比例风险回归模型显示,高血压动脉粥样硬化组心力衰竭的风险比(HR)为 3.08(95%置信区间[CI]:1.32-7.16),而在用降脂、降糖和降压药物逐渐校正后,HR 降至 2.38(95%CI:1.01-5.63)。亚组分析和敏感性分析与总人群一致。总之,暴露于高血压和动脉粥样硬化的糖尿病患者心力衰竭风险增加,而降脂、降糖和降压药物的使用可降低这种风险。